Zenotech reports loss as September quarter revenue falls 40 percent

Revenue DeclinePat NegativeEbitda Margin CompressionExceptional ItemNegative Operating CashflowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹38.40

prior close

₹37.79

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 170sector+0.6%-2.2% vs sector

On the reaction day the stock moved 2.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+0.8

15m

+0.8

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6pendingpending+0.6-2.2

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

For the quarter and half year ended September 30, 2026, the board approved unaudited results. Revenue from operations fell 40 percent to Rs 613.15 lakh from Rs 1,023.19 lakh, and the quarterly net loss widened to Rs 257.33 lakh from Rs 83.65 lakh. Half-year revenue fell 16.7 percent to Rs 1,572.79 lakh from Rs 1,887.10 lakh, while the result moved from Rs 15.30 lakh profit to Rs 302.88 lakh loss. Operating cash outflow was Rs 593.29 lakh.

Likely market impact

Lower sales, a wider loss and cash burn may pressure earnings and the share price, though cash of Rs 2,854.12 lakh offers some support.